Cytometry Part B: Clinical Cytometry最新文献

{"title":"Issue highlights—June 2025","authors":"Joseph A. DiGiuseppe","doi":"10.1002/cyto.b.22239","DOIUrl":"https://doi.org/10.1002/cyto.b.22239","url":null,"abstract":"","PeriodicalId":10883,"journal":{"name":"Cytometry Part B: Clinical Cytometry","volume":"108 3","pages":"195-197"},"PeriodicalIF":2.3,"publicationDate":"2025-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144179068","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Remembering Dr. Bruce H. Davis: A passionate leader in clinical flow cytometry","authors":"","doi":"10.1002/cyto.b.22240","DOIUrl":"https://doi.org/10.1002/cyto.b.22240","url":null,"abstract":"","PeriodicalId":10883,"journal":{"name":"Cytometry Part B: Clinical Cytometry","volume":"108 3","pages":"189-194"},"PeriodicalIF":2.3,"publicationDate":"2025-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144179067","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Intraoperative flow cytometry in detecting free carcinoma cells in peritoneal lavage fluid of gastric carcinoma cases.","authors":"Thulasi Raman Ramalingam, Bharaneedharan Marimuthu, Harsha N Rasheed, Archana Lakshmanan, Swetha Lakshmi Narla, Lakshman Vaidhyanathan, Ajit Pai","doi":"10.1002/cyto.b.22238","DOIUrl":"https://doi.org/10.1002/cyto.b.22238","url":null,"abstract":"<p><p>The free carcinoma cells (FCC) in peritoneal lavage fluid are an independent adverse prognostic factor in patients with gastric carcinoma. Detection of FCC in the pre-operative peritoneal lavage fluid is critical, as patients with FCC do not have a survival advantage with curative cytoreductive (CCR) surgery. Cytology is currently used to assess FCC, but its sensitivity is poor and there is a need for better sensitive techniques. We attempted to study the efficiency of intra-operative flow cytometry (FCM) in detecting FCC in peritoneal lavage fluid of gastric carcinoma patients. In this prospective study, 32 peritoneal lavage fluids were analyzed intra-operatively by cytology and FCM. The median time taken for sample processing was 47 min. The concordance was achieved in 84% (27/32) of samples. FCM detected FCC in 17 peritoneal lavage fluids, of which only 12 were reported positive by cytology. Five cases that had a FCC burden of less than 0.01% were reported negative by cytology. FCC with programmed death-ligand 1 (PD-L1) expression of greater than 50% was noted in 12 cases. Intra-operative FCM improves the detection of FCC in peritoneal lavage fluid compared to cytology. Due to higher sensitivity, flow cytometry offers a promising adjuvant to cytology and helps in deciding on judicious radical CCR.</p>","PeriodicalId":10883,"journal":{"name":"Cytometry Part B: Clinical Cytometry","volume":" ","pages":""},"PeriodicalIF":2.3,"publicationDate":"2025-05-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144141761","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Comparison of monoclonal antibody to CD59 for the diagnosis of paroxysmal nocturnal hemoglobinuria by flow cytometry.","authors":"Nikiforova Kseniya Alexandrovna, Kapranov Nikolai Mikhailovich, Davydova Yulia Olegovna, Fidarova Zalina Taymurazovna, Galtseva Irina Vladimirovna, Parovnichnikova Elena Nikolaevna","doi":"10.1002/cyto.b.22237","DOIUrl":"https://doi.org/10.1002/cyto.b.22237","url":null,"abstract":"","PeriodicalId":10883,"journal":{"name":"Cytometry Part B: Clinical Cytometry","volume":" ","pages":""},"PeriodicalIF":2.3,"publicationDate":"2025-05-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143994072","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Detection of circulating tumor cells is achieved by flow cytometry in melanoma patients.","authors":"Ludivine Fourdrain, Théo Brochet, Valentin Clichet, Guillaume Chaby, Brigitte Gubler, Loïc Garçon, Jean-Philippe Arnault, Thomas Boyer","doi":"10.1002/cyto.b.22236","DOIUrl":"https://doi.org/10.1002/cyto.b.22236","url":null,"abstract":"<p><p>Melanoma is an aggressive skin tumor whose incidence is rising sharply, and for which the determination of new prognostic factors is a major challenge. In oncology, circulating tumor cells (CTCs) are at the heart of much research, as they represent a source of tumor material obtained non-invasively by liquid biopsy. With this in mind, this prospective, longitudinal study looked at the detection of CTCs in melanoma patients using the flow cytometry technique, and constitutes a proof-of-principle study, as molecular biology is the most widely used technique today to detect CTCs. The labeling strategy showed high sensitivity and specificity for melanoma cells. All 35 patients in the cohort presented at least one CTC at inclusion, demonstrating that the cells circulate regardless of the stage of the disease. However, a significant increase in the number of CTCs was observed in metastatic stages compared with non-metastatic stages. With regard to the main prognostic factors for melanoma, no significant association was found between the number of CTCs and Breslow thickness or the presence of ulceration. This study must be continued in order to increase the size of the sample, with a more consistent longitudinal follow-up, in order to gain a better understanding of the prognostic significance of CTCs.</p>","PeriodicalId":10883,"journal":{"name":"Cytometry Part B: Clinical Cytometry","volume":" ","pages":""},"PeriodicalIF":2.3,"publicationDate":"2025-04-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143994134","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Methodology of high-dimensional flow cytometry in monitoring immune microenvironment of pituitary neuroendocrine tumors","authors":"Marina Yu Loguinova,&nbsp;Valeria V. Mazeeva,&nbsp;Daria V. Lisina,&nbsp;Elena N. Zakharova,&nbsp;Alyona V. Sorokina,&nbsp;Lilya U. Dzhemileva,&nbsp;Andrei Yu Grigoriev,&nbsp;Alexandra S. Shutova,&nbsp;Ekaterina A. Pigarova,&nbsp;Larisa K. Dzeranova,&nbsp;Galina A. Melnichenko,&nbsp;Natalia G. Mokrysheva,&nbsp;Sergei A. Rumiantsev,&nbsp;Vladimir P. Chekhonin","doi":"10.1002/cyto.b.22235","DOIUrl":"10.1002/cyto.b.22235","url":null,"abstract":"<p>Characterization of the tumor immune microenvironment (TIME) of pituitary neuroendocrine tumors (PitNETs) is crucial for understanding the behavior of different types of PitNETs and identification of possible causes of their aggressiveness, rapid growth, and resistance to therapy. High-dimensional flow cytometry (FC) is a promising technology for studying TIME but poses unique technical challenges, especially when applied to solid tissues and PitNETs, in particular. This paper evaluates the potential of FC for analyzing TIME in PitNETs by addressing methodological difficulties across all stages of the workflow and proposing solutions. We developed a protocol for preparing single-cell suspensions from PitNET tissues for FC. This involved optimization of enzymatic digestion and comparison of it with mechanical tissue dissociation assessing cell yield, viability, and target antigen expression. We designed four multicolor FC panels to analyze major lymphocyte and myeloid cell subsets including determination of subpopulations of T, B, NK cells and their activation and cytotoxic potential, neutrophils, monocytes, CD68 + CD64 + CD11b^low macrophages of M2 and M1 subtypes, and two types of myeloid suppressor cells - PMN-MDSC and M-MDSC. Principles of multicolor panel design, spreading error, and importance of voltage balance for proper flow cytometer setting are discussed. The panels were validated and demonstrated the feasibility of their simultaneous use on pituitary tumor surgical tissue for comprehensive TIME characterization. We compared lymphocyte frequencies in blood, PitNETs, and three sequential PitNET eluates to find out the contamination level of PitNET samples with blood leukocytes. To address technical challenges, we propose a strategy of logical data gating that removes spurious signals from aggregates, dead cells, and subcellular debris that can interfere with analysis. Our results indicate that despite all technical difficulties, multiparametric FC can effectively characterize different types of PitNETs. This enhanced understanding of the immune infiltrate provides valuable insights into PitNET biology and advances clinical diagnostics.</p>","PeriodicalId":10883,"journal":{"name":"Cytometry Part B: Clinical Cytometry","volume":"108 3","pages":"234-251"},"PeriodicalIF":2.3,"publicationDate":"2025-04-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/cyto.b.22235","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143984317","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Highlights March 2025","authors":"Marie C. Béné","doi":"10.1002/cyto.b.22234","DOIUrl":"https://doi.org/10.1002/cyto.b.22234","url":null,"abstract":"","PeriodicalId":10883,"journal":{"name":"Cytometry Part B: Clinical Cytometry","volume":"108 2","pages":"105-107"},"PeriodicalIF":2.3,"publicationDate":"2025-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143741551","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"28-color single tube for flow cytometric assessment of myeloid maturation, myeloid neoplasia, and acute myeloid leukemia minimal/measurable residual disease","authors":"Qi Gao,&nbsp;Alexander Chan,&nbsp;Jingping Zhang,&nbsp;Xiaotian Sun,&nbsp;Amanda Burke,&nbsp;Olivia Miu,&nbsp;Nghia Nguyen,&nbsp;Shu Jie Zhang,&nbsp;Jennifer Reminick,&nbsp;Jessica Wardrope,&nbsp;Mikhail Roshal","doi":"10.1002/cyto.b.22233","DOIUrl":"10.1002/cyto.b.22233","url":null,"abstract":"<p>Flow cytometry (FC) is an indispensable tool for myeloid neoplasia (MN) diagnosis, and the cell of origin has clinical diagnostic and prognostic significance. However, the complex maturational pathways within the blast compartment complicate the detection of the abnormal population at the minimal/measurable disease (MRD) level using the difference from normal approach. The analysis could be simplified by separating the blast compartment into maturation-defined stages with relatively uniform phenotypes as reference populations. This requires a relatively extensive panel of antibodies to define maturation stages and simultaneously detect the common deviations from the normal pattern. We validated a single tube 28-color clinical assay for MN assessment and acute myeloid leukemia (AML) MRD detection assisted by the precise maturation stage assignment. The new assay uses a previously described 21-antigen backbone, with the additions of CD10, CD36, CD42b, CD45RA, CD90, CD105, and CD371. Validation was performed using 37 normal samples and 151 MN follow-up samples in a split-sample fashion comparing the new assay to the legacy 3-tube, 21-antigen assay. Dilution studies were performed to establish assay sensitivity. A new analysis framework relying on comparison to well-defined maturational stages was established for MRD analysis. The assays showed 100% qualitative concordance with excellent quantitative concordance. Dilution studies yielded a limit of detection of 0.01%. The addition of new antibodies allowed for consistent comparisons of candidate abnormal populations to well-defined normal maturation stages through traditional FC plots and Uniform Matrix Approximation and Projection assessments. This new single-tube, 28-color clinical assay allows for efficient MN assessment in clinical settings. It reliably detects MRD levels of abnormal myeloid cells because the expanded panel allows for precise comparison to defined lineage commitment maturational stages. Lastly, it provides high information density while reducing equipment use, reagent use, and technical labor.</p>","PeriodicalId":10883,"journal":{"name":"Cytometry Part B: Clinical Cytometry","volume":"108 3","pages":"198-211"},"PeriodicalIF":2.3,"publicationDate":"2025-03-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143708958","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Unraveling genotype-phenotype associations and predictive modeling of outcome in acute myeloid leukemia.","authors":"Artuur Couckuyt, Sofie Van Gassen, Annelies Emmaneel, Vince Janda, Malicorne Buysse, Ine Moors, Jan Philippé, Mattias Hofmans, Tessa Kerre, Yvan Saeys, Sarah Bonte","doi":"10.1002/cyto.b.22230","DOIUrl":"https://doi.org/10.1002/cyto.b.22230","url":null,"abstract":"<p><p>Acute myeloid leukemia (AML) comprises 32% of adult leukemia cases, with a 5-year survival rate of only 20-30%. Here, the immunophenotypic landscape of this heterogeneous malignancy is explored in a single-center cohort using a novel quantitative computational pipeline. For 122 patients who underwent induction treatment with intensive chemotherapy, leukemic cells were identified at diagnosis, computationally preprocessed, and quantitatively subtyped. Computational analysis provided a broad characterization of inter- and intra-patient heterogeneity, which would have been harder to achieve with manual bivariate gating. Statistical testing discovered associations between CD34, CD117, and HLA-DR expression patterns and genetic abnormalities. We found the presence of CD34⁺ cell populations at diagnosis to be associated with a shorter time to relapse. Moreover, CD34^- CD117⁺ cell populations were associated with a longer time to AML-related mortality. Machine learning (ML) models were developed to predict 2-year survival, European LeukemiaNet (ELN) risk category, and inv(16) or NPM1^mut, based on computationally quantified leukemic cell populations and limited clinical data, both readily available at diagnosis. We used explainable artificial intelligence (AI) to identify the key clinical characteristics and leukemic cell populations important for our ML models when making these predictions. Our findings highlight the importance of developing objective computational pipelines integrating immunophenotypic and genetic information in the risk stratification of AML.</p>","PeriodicalId":10883,"journal":{"name":"Cytometry Part B: Clinical Cytometry","volume":" ","pages":""},"PeriodicalIF":2.3,"publicationDate":"2025-03-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143662791","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Hierarchical clustering of clinical and flow cytometry parameters is associated with deterioration in patients with community-acquired pneumonia in the emergency department: A preliminary study.","authors":"Thomas Lafon, Robin Jeannet, Thomas Daix, Guillaume Monneret, Jean Feuillard","doi":"10.1002/cyto.b.22232","DOIUrl":"https://doi.org/10.1002/cyto.b.22232","url":null,"abstract":"<p><p>Anticipating the evolution of septic patients with community-acquired pneumonia (CAP) is challenging for front-line physicians in the Emergency Department (ED). Prognosis depends mainly on early identification, antibiotics, organ support, but also immune status. The objective of this proof-of-concept study was to perform a cluster analysis to investigate whether specific phenotypes, including cellular immunology parameters, are associated with the prognosis in patients with CAP presenting to the ED. We performed an exploratory study in the ED of Limoges university hospital (France) on patients with a confirmed CAP. Deterioration was defined by a composite criterion monitored during 7 days following admission: (i) acute respiratory failure with a high flow oxygen requirement, (ii) subsequent ICU admission, (iii) shock, (iv) worsening of organ dysfunction, and (v) in-hospital mortality. Multicolor Flow Cytometry (MFC) was performed within 12 h after ED admission. Monocyte HLA-DR (mHLA-DR) panels consisting of 11 colors for neutrophils and eight colors for lymphocytes were utilized. Phenotypes were defined using non-supervised hierarchical clustering, including 65 clinical, biological, and immunological variables. During 5 months, 63 patients were prospectively studied (age = 66 ± 19 years; 38 men [60%]; SOFA score = 2.6 ± 1.5; Sepsis = 71%; in-hospital mortality = 5%) of whom 11 patients (17%) were assigned to the deterioration group. Upon admission, we observed no differences in any markers or in the demographic or clinical characteristics of the patients. In contrast, by performing hierarchical clustering, we identified three groups: Cluster #1 corresponded to a population with a low deterioration (5%) compared with Clusters #2 (23%) and #3 (31%). Markers from the myeloid lineage, including mHLA-DR, immature neutrophils, and CD64+ neutrophils, were among the parameters discriminating for cluster construction. Cluster #3 displayed the most severe profile, characterized by elevated markers such as CRP, PCT, and immature granulocytes, along with reduced mHLA-DR levels. A clustering strategy, based on myeloid markers obtained through flow cytometry, provided prognostic insights by identifying three phenotypes with distinct outcomes, while none of the individual markers studied (n = 65, both clinical and biological) showed similar prognostic value. A panel of myeloid markers, alongside clinical management, could optimize patient triage and resource allocation upon ED admission.</p>","PeriodicalId":10883,"journal":{"name":"Cytometry Part B: Clinical Cytometry","volume":" ","pages":""},"PeriodicalIF":2.3,"publicationDate":"2025-03-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143596623","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}